Bruker introduces novel NMR solutions at ENC 2017
New magnetic resonance technologies and applications open new frontiers for biological, chemical and materials research and routine analysis in pharmaceutical and chemical industries.
At the 58th Experimental Nuclear Magnetic Resonance Conference, Bruker announced new software and hardware addressing the need for enhanced workflow solutions for NMR spectroscopy research and analysis. These solutions will benefit researchers in many disciplines of NMR, while providing productivity enhancements for pharmaceutical users.
Rainer Kuemmerle, NMR Product Manager for the Bruker BioSpin Magnetic Resonance Spectroscopy division, explained: “We always have our customers in mind when developing new technologies and applications, and these latest NMR solutions exemplify this mindset. From academic, to pharma, and to chemical and advanced materials customers, we focus on making our customers successful by enhancing their productivity and expanding their range of NMR applications.”
New Software
TopSpin 4 is the next generation of Bruker’s NMR software for spectrometer control and data analysis, designed for the newly introduced AVANCE NEO platform. The combination of a new user interface and capabilities to support multiple receivers and other AVANCE NEO capabilities, will make TopSpin 4 a very powerful and intuitive software for NMR spectroscopists. Existing AVANCE III HD customers will also benefit from a new TopSpin 3.5 version, as we continue enhancements and support for the Avance III HD platform.
Designed to simplify and accelerate the setup of biomolecular NMR experiments, the new bioTop module performs most biomolecular tasks in full automation. Only minimal user interaction is required for most experiments. The process starts after inserting the sample, taking care of shimming, locking and tuning if necessary. From experiment selections to final processed spectra, including optimization of commonly used parameters, bioTop can be customized to accommodate much of the workflow in biomolecular NMR laboratories.
The new TopSolids module is an intuitive, workflow-based software for solid-state NMR. TopSolids is designed to give easy access to the delicate setup of probe hardware and complex solid-state NMR experiments, e.g. from structural biology on membrane proteins, to pharmaceutical comounds, to catalysis, battery research, polymer or material science work. For any customer who could benefit from solid-state NMR, TopSolids 2.0 will be a great productivity tool, decreasing the time for setup and providing even more results, for novice and expert users.
Of particular interest to biotech and pharma customers are two novel solutions:
For NMR detection, Bruker is pleased to introduce the new iProbe platform. This novel NMR probe architecture allows not only for an increase in signal to noise, and faster and more accurate rf tuning, but also provides a more flexible design that allows easier customization of NMR probes for dedicated applications. The first probes introduced on this platform include the industry-leading SmartProbe iProbes, available now from 400-600 MHz, offering up to 10% increase in sensitivity.
The InsightMR portfolio of applications for monitoring chemical and biological processes is expanding further, to increase understanding of reaction mechanisms, chemical processes as well as cell metabolism. InsightXpress now enhances the NMR monitoring of fast reactions and rapid, automated, screening of reactions conditions. For studies on living cells, InsightCell now monitors living cells to study their biological activity through direct NMR measurements of variations in metabolite concentration.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance